Cowen Inc’s Biogen BIIB Stock Holding History

Cowen Inc’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,000	Closed	-$1.36M	–	232
2017 Q2	$1.36M	Buy	+5,000	New	+$1.32M	0.07%	147

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cowen Inc's BIIB Position: Q3 2017 in Review

Cowen Inc sold out of Biogen (BIIB) in Q3 2017, closing a stake of 2,000 shares — an estimated $543K sold.

Cowen Inc first reported a position in BIIB in Q2 2014 and held it in 7 quarters. The position peaked at $2.42M in Q1 2015. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

Cowen Inc reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
Cowen Inc sold 2,000 Biogen shares in Q3 2017, an estimated $543K.
Cowen Inc first reported a position in Biogen in Q2 2014 and held it in 7 quarters.
Cowen Inc's Biogen position peaked at $2.42M in Q1 2015.
1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Cowen Inc's 13F filing for Q3 2017, filed 14 Nov 2017.